Nature's Sunshine rises on currency exchange
This article was originally published in The Tan Sheet
Executive Summary
Favorable exchange rates in certain international markets, coupled with selective price increases, help Nature's Sunshine Products grow net sales revenue 4.7 percent to $87 million in the supplement direct-seller's first quarter. The global performance countered the effects of Venezuela's devaluation of the bolivar, which was a prime factor in Venezuelan net sales falling 53.1 percent to $1.5 million in the January-March period. The Provo, Utah-based company May 7 reported first-quarter net income of $4.2 million, compared to a loss of $1.5 million in the year-ago period. Diluted net income per share was 27 cents, versus a net loss of 9 cents a share in the 2009 quarter
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.